Fakultni nemocnice Motol; Neurologicka klinika

Prague 150 06

0 studies enrolling now · 2 studies all time

What they study most

Malignant Melanoma, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Completed
• A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma — Completed